OCLASSEN GLENN A 4
4 · Verrica Pharmaceuticals Inc. · Filed Jun 19, 2018
Insider Transaction Report
Form 4
OCLASSEN GLENN A
Director
Transactions
- Conversion
Common Stock
2018-06-19+200,734→ 290,421 total(indirect: See Footnote) - Conversion
Series A Convertible Preferred Stock
2018-06-19−200,734→ 0 total(indirect: See Footnote)→ Common Stock (200,734 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The shares are held directly by The Glenn A. Oclassen 2016 Trust dated November 30, 2016 (the "Trust"). The Reporting Person serves as trustee of the Trust.